5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study (Q46297381)

21 December 2017

title

5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study (English)

1 reference

21 December 2017

1 reference

1 reference

1 reference

1

Elizabeth Molyneux

1 reference

21 December 2017

author name string

Shaikh Qamaruddin Nizami

2

1 reference

21 December 2017

Samir Saha

3

1 reference

21 December 2017

Khanh Truong Huu

4

1 reference

21 December 2017

Matloob Azam

5

1 reference

21 December 2017

Zulfiqar Ahmad Bhutta

6

1 reference

21 December 2017

Ramadan Zaki

7

1 reference

21 December 2017

Martin Willi Weber

8

1 reference

21 December 2017

Shamim Ahmad Qazi

9

1 reference

21 December 2017

CSF 5 Study Group

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

377

1 reference

21 December 2017

issue

9780

1 reference

21 December 2017

page(s)

1837-1845

1 reference

21 December 2017

Sequelae due to bacterial meningitis among African children: a systematic literature review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Acute bacterial meningitis in The Gambia: a four-year review of paediatric hospital admissions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

High prevalence of children colonized with penicillin-resistant Streptococcus pneumoniae in public day-care centers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Pneumococcal resistance to the third-generation cephalosporins: clinical, laboratory and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Pharmacokinetics of ceftriaxone in neonates and infants with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Duration of treatment in bacterial meningitis: a historical inquiry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Don't keep taking the tablets?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Ceftriaxone versus penicillin G in the short-term treatment of meningococcal meningitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Five days of antibacterial therapy for bacterial meningitis in children?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Revision of the International Classification of Impairments, Disabilities, and Handicaps: developmental issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Revision of a Parent-Completed Developmental Screening Tool: Ages and Stages Questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Pathogenesis and pathophysiology of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Clinical predictors for hearing loss in children with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Dexamethasone and bacterial meningitis in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Hearing impairment after bacterial meningitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

Antibiotics for Salmonella meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960580-1

7 January 2021

10.1016/S0140-6736(11)60580-1

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017